Prospective Health Technology Assessment
Innovative Method for Technology Foresight and Strategic Planning
for Medical Product Portfolios
The main objective of ProHTA® is to provide an assessment of the economic and
medical impact of healthcare innovations.
ProHTA® focuses on requirements for a medical product portfolio in early development phases in order:
ProHTA® answers two significant questions:
What are the impacts of an innovation?
What does a technology have to look like to provide a specific impact?
ProHTA® enables a sound portfolio planning, defining political, economic and technical selling propositions.
ProHTA® driven knowledge improves decision making, aligning an innovation to the market needs.